Drugs / IN-A001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05005065 | Sep → Nov 2021 | — | HK inno.N Corporation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IN-A001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05005065 ↗ |
| Route | Oral | “after oral administration” NCT05005065 ↗ |